Soizic Garaud Selected Research

Tertiary Lymphoid Structures

1/2022	T follicular helper and B cell crosstalk in tertiary lymphoid structures and cancer immunotherapy.
1/2018	Antigen Specificity and Clinical Significance of IgG and IgA Autoantibodies Produced in situ by Tumor-Infiltrating B Cells in Breast Cancer.
1/2018	Quantifying Tertiary Lymphoid Structure-Associated Genes in Formalin-Fixed Paraffin-Embedded Breast Cancer Tissues.
1/2017	Immune Checkpoint Molecules on Tumor-Infiltrating Lymphocytes and Their Association with Tertiary Lymphoid Structures in Human Breast Cancer.
1/2017	Reliability of tumor-infiltrating lymphocyte and tertiary lymphoid structure assessment in human breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Soizic Garaud Research Topics

Disease

17	Neoplasms (Cancer) 01/2022 - 07/2013
7	Breast Neoplasms (Breast Cancer) 01/2021 - 07/2013
5	Tertiary Lymphoid Structures 01/2022 - 01/2017
2	Neoplasm Metastasis (Metastasis) 01/2022 - 11/2019
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2019 - 04/2011
1	Renal Cell Carcinoma (Grawitz Tumor) 02/2022
1	Cholestasis 02/2022
1	Melanoma (Melanoma, Malignant) 01/2022
1	Pneumonia (Pneumonitis) 04/2021
1	Hepatocellular Carcinoma (Hepatoma) 02/2020
1	Pathologic Complete Response 08/2017
1	Autoimmune Diseases (Autoimmune Disease) 08/2010
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 11/2007

Drug/Important Bio-Agent (IBA)

3	CytokinesIBA 01/2019 - 08/2010
3	AutoantibodiesIBA 01/2018 - 11/2007
2	Immune Checkpoint InhibitorsIBA 02/2022 - 04/2021
2	NivolumabIBA 02/2022 - 01/2022
2	Phenobarbital (Luminal)FDA Link 01/2021 - 12/2020
2	Hormones (Hormone)IBA 01/2019 - 01/2017
2	ChemokinesIBA 01/2019 - 07/2013
2	Formaldehyde (Formol)FDA Link 01/2018 - 08/2017
2	ParaffinIBA 01/2018 - 08/2017
1	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2022
1	Tyrosine Kinase InhibitorsIBA 02/2022
1	cabozantinibIBA 02/2022
1	IpilimumabIBA 01/2022
1	6-methyladenineIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Alpha-Ketoglutarate-Dependent Dioxygenase FTOIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	N-methyladenosineIBA 01/2021
1	Denosumab FDA Link 12/2020
1	SirtuinsIBA 02/2020
1	Thymic Stromal LymphopoietinIBA 11/2019
1	Messenger RNA (mRNA)IBA 01/2019
1	Immunoglobulin G (IgG)IBA 01/2018
1	EnzymesIBA 01/2018
1	5-Methylcytosine (5 Methylcytosine)IBA 01/2018
1	Immunoglobulin A (IgA)IBA 01/2018
1	AntigensIBA 01/2018
1	AntibodiesIBA 01/2018
1	Estrogen ReceptorsIBA 01/2018
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2018
1	human ERBB2 proteinIBA 01/2018
1	5-hydroxymethylcytosineIBA 01/2018
1	Estrogens (Estrogen)FDA Link 01/2018
1	hydrogen sulfite (bisulfite)IBA 08/2017
1	AnthracyclinesIBA 08/2017
1	DNA (Deoxyribonucleic Acid)IBA 08/2017
1	Chemotactic FactorsIBA 06/2017
1	Immune Checkpoint ProteinsIBA 01/2017
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2017
1	Hematoxylin (Haematoxylon)IBA 01/2017
1	ElementsIBA 07/2013
1	Interleukin-10 (Interleukin 10)IBA 04/2011
1	AutoantigensIBA 08/2010
1	Interleukin-6 (Interleukin 6)IBA 11/2007
1	Immunoglobulin Variable RegionIBA 11/2007

Therapy/Procedure

5	Immunotherapy 01/2022 - 02/2020
4	Therapeutics 02/2022 - 08/2017
1	Radiotherapy 02/2020